Cannell Capital - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 16 filers reported holding LAVA THERAPEUTICS NV in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q1 2023$29,805
-52.6%
17,9550.0%0.01%
-53.8%
Q4 2022$62,843
-23.4%
17,9550.0%0.01%
-31.6%
Q3 2022$82,000
+583.3%
17,955
+342.5%
0.02%
+850.0%
Q2 2022$12,0004,0580.00%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q3 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 771,874$1,150,0920.39%
Novo Holdings A/S 2,400,000$3,528,0000.26%
Redmile Group, LLC 2,074,372$3,090,8140.15%
Alpha Wave Global, LP 109,097$162,5550.10%
Artal Group S.A. 200,000$2940.01%
Tower Research Capital LLC (TRC) 11,960$17,5810.00%
OSAIC HOLDINGS, INC. 48$710.00%
PNC FINANCIAL SERVICES GROUP, INC. 65,000$95,5500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$1490.00%
View complete list of LAVA THERAPEUTICS NV shareholders